Practices and activities among healthcare personnel with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection working in different healthcare settings-ten Emerging Infections Program sites, April-November 2020.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
08 2022
Historique:
pubmed: 3 6 2021
medline: 4 8 2022
entrez: 2 6 2021
Statut: ppublish

Résumé

Healthcare personnel with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection were interviewed to describe activities and practices in and outside the workplace. Among 2,625 healthcare personnel, workplace-related factors that may increase infection risk were more common among nursing-home personnel than hospital personnel, whereas selected factors outside the workplace were more common among hospital personnel.

Identifiants

pubmed: 34075869
pii: S0899823X21002622
doi: 10.1017/ice.2021.262
pmc: PMC8207549
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1058-1062

Auteurs

Nora Chea (N)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Taniece Eure (T)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Chenega Professional & Technical Services, Chesapeake, Virginia.

Austin R Penna (AR)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Cedric J Brown (CJ)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Chenega Professional & Technical Services, Chesapeake, Virginia.

Joelle Nadle (J)

California Emerging Infections Program, Oakland, California.

Deborah Godine (D)

California Emerging Infections Program, Oakland, California.

Linda Frank (L)

California Emerging Infections Program, Oakland, California.

Christopher A Czaja (CA)

Colorado Department of Public Health and Environment, Denver, Colorado.

Helen Johnston (H)

Colorado Department of Public Health and Environment, Denver, Colorado.

Devra Barter (D)

Colorado Department of Public Health and Environment, Denver, Colorado.

Betsy Feighner Miller (BF)

Colorado Department of Public Health and Environment, Denver, Colorado.

Katie Angell (K)

Colorado Department of Public Health and Environment, Denver, Colorado.

Kristen Marshall (K)

Colorado Department of Public Health and Environment, Denver, Colorado.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.

James Meek (J)

Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut.

Monica Brackney (M)

Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut.

Stacy Carswell (S)

Georgia Emerging Infections Program, Atlanta Veterans Affairs Medical Center, Foundation for Atlanta Veterans Education and Research, Atlanta, Georgia.

Stepy Thomas (S)

Georgia Emerging Infections Program, Emory University School of Medicine, Atlanta, Georgia.

Lucy E Wilson (LE)

Maryland Department of Health, Baltimore, Maryland.

Rebecca Perlmutter (R)

Maryland Department of Health, Baltimore, Maryland.

Kaytlynn Marceaux-Galli (K)

Maryland Department of Health, Baltimore, Maryland.

Ashley Fell (A)

Minnesota Department of Health, St Paul, Minnesota.

Sarah Lim (S)

Minnesota Department of Health, St Paul, Minnesota.

Ruth Lynfield (R)

Minnesota Department of Health, St Paul, Minnesota.

Sarah Shrum Davis (SS)

New Mexico Emerging Infections Program, University of New Mexico, Albuquerque, New Mexico.

Erin C Phipps (EC)

New Mexico Emerging Infections Program, University of New Mexico, Albuquerque, New Mexico.

Marla Sievers (M)

New Mexico Department of Health, Santa Fe, New Mexico.

Ghinwa Dumyati (G)

New York Emerging Infections Program, University of Rochester Medical Center, Rochester, New York.

Cathleen Concannon (C)

New York Emerging Infections Program, University of Rochester Medical Center, Rochester, New York.

Kathryn McCullough (K)

New York Emerging Infections Program, University of Rochester Medical Center, Rochester, New York.

Amy Woods (A)

New York Emerging Infections Program, University of Rochester Medical Center, Rochester, New York.

Sandhya Seshadri (S)

New York Emerging Infections Program, University of Rochester Medical Center, Rochester, New York.

Christopher Myers (C)

New York Emerging Infections Program, University of Rochester Medical Center, Rochester, New York.

Rebecca Pierce (R)

Public Health Division, Oregon Health Authority, Portland, Oregon.

Valerie L S Ocampo (VLS)

Public Health Division, Oregon Health Authority, Portland, Oregon.

Judith A Guzman-Cottrill (JA)

Public Health Division, Oregon Health Authority, Portland, Oregon.

Gabriela Escutia (G)

Public Health Division, Oregon Health Authority, Portland, Oregon.

Monika Samper (M)

Public Health Division, Oregon Health Authority, Portland, Oregon.

Sandra A Pena (SA)

Tennessee Department of Health, Nashville, Tennessee.

Cullen Adre (C)

Tennessee Department of Health, Nashville, Tennessee.

Matthew Groenewold (M)

Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio.

Nicola D Thompson (ND)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Shelley S Magill (SS)

Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH